iRhythm Holdings (IRTC) Cash from Investing Activities (2015 - 2026)

iRhythm Holdings' (IRTC) quarterly Cash from Investing Activities came in at $30.2 million in Q1 2026, up 179.22% year-on-year from $10.8 million in Q1 2025, and up 161.92% on a QoQ basis from -$48.8 million in Q4 2025.

iRhythm Holdings (IRTC) Cash from Investing Activities (2015 - 2026) Analysis & Trends

iRhythm Holdings (IRTC) has 12 years of Cash from Investing Activities data on file, last reported at $30.2 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 179.22% year-over-year to $30.2 million in Q1 2026; TTM through Mar 2026 was -$208.7 million, a 3.77% decrease from a year earlier, with the FY2025 full-year figure at -$277.1 million, down 125.28% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $30.2 million, up from -$48.8 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for IRTC reached as high as $40.0 million in Q1 2024 and fell as low as -$122.2 million in Q4 2024.
  • Historically, Cash from Investing Activities has averaged -$24.9 million across 5 years, with a median of -$8.5 million in 2022.
  • Across the five-year window, Cash from Investing Activities surged 2190.26% in 2023 and plunged 8825.64% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$8.1 million in 2022, then jumped by 117.25% to $1.4 million in 2023, then plunged by 8825.64% to -$122.2 million in 2024, then surged by 60.05% to -$48.8 million in 2025, then surged by 161.92% to $30.2 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $30.2 million in Q1 2026, -$48.8 million in Q4 2025, and -$89.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 iRhythm Holdings 3.65 Bn 3.10 Bn 141.35 Mn 30.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.22 Mn
Mar 31, 2026 30.22 Mn
Dec 31, 2025 -48.80 Mn
Dec 31, 2025 -48.80 Mn
Sep 30, 2025 -89.20 Mn
Sep 30, 2025 -89.20 Mn
Jun 30, 2025 -100.92 Mn
Jun 30, 2025 -100.92 Mn
Mar 31, 2025 -38.14 Mn
Mar 31, 2025 -38.14 Mn
Dec 31, 2024 -122.16 Mn
Dec 31, 2024 -122.16 Mn
Sep 30, 2024 -55.33 Mn
Sep 30, 2024 -55.33 Mn
Jun 30, 2024 14.51 Mn
Jun 30, 2024 14.51 Mn
Mar 31, 2024 40.00 Mn
Mar 31, 2024 40.00 Mn
Dec 31, 2023 1.40 Mn
Dec 31, 2023 1.40 Mn